Laboratory of Molecular Immunology, Federal State Budgetary Institution "Research Institute of Fundamental and Clinical Immunology", Yadrintsevskaya St. 14, Novosibirsk, 630099, Russia.
Novosibirsk State University, Pirogova St. 2, Novosibirsk, 630090, Russia.
J Immunol Res. 2019 Apr 18;2019:7029726. doi: 10.1155/2019/7029726. eCollection 2019.
Dendritic cells (DCs) control immune responses by modulating T and B cells towards effector or tolerogenic responses. In this study, we evaluated the effects of different immunosuppressive molecules on the phenotypic and functional characteristics of primary dendritic cells from C57BL/6 and CBA mice.
DCs were derived from bone marrow cells in the presence of rmGM-CSF and rmIL-4. DCs were then treated with different types of immunosuppressive molecules (rmIL-10, rmTGF-, and BAY 11-7082) and cocultured with syngeneic splenocytes. The amount of CD4+CD25hiFoxP3+ Tregs, IL-10 expression, and proliferation were evaluated.
Tolerogenic factors were found to have different effects on DCs C57Bl/6 mice. In C57Bl/6 mice, BAY 11-7082 alone had no effect on the expression of DC maturation molecules (CD80, CD86). Transforming growth factor beta (TGF-), alone and in combination with BAY 11-7082, reduced the expression of these molecules. Cocultivation of DCs with splenocytes in the presence of TGF- and BAY 11-7082 favored regulatory T cell (CD4+CD25hiFoxP3+) differentiation and disfavored differentiation of CD4+ T cells producing IL-10. In CBA mice, we found that rmIL-10 and rmTGF- have a weak effect on maturation of DCs and their functional properties to induce Treg cells and IL-10 production.
These results indicate that TGF- and IL-10 have different effects on the phenotypic and functional characteristics of DCs and that the NF-B inhibitor, BAY 11-7082, has no synergistic effect on these treatments. In mice with an opposite nature of the immune response, the effects of immunoregulatory cytokines (IL-10 and TGF-b) differ on maturation of dendritic cells.
树突状细胞(DCs)通过调节 T 和 B 细胞向效应或耐受反应,控制免疫应答。在这项研究中,我们评估了不同免疫抑制分子对 C57BL/6 和 CBA 小鼠原代树突状细胞表型和功能特征的影响。
在 rmGM-CSF 和 rmIL-4 的存在下,从骨髓细胞中衍生出 DCs。然后,用不同类型的免疫抑制分子(rmIL-10、rmTGF-和 BAY 11-7082)处理 DCs,并与同基因脾细胞共培养。评估 CD4+CD25hiFoxP3+Tregs 的数量、IL-10 的表达和增殖。
在 C57Bl/6 小鼠中,发现耐受原性因子对 DCs 有不同的影响。BAY 11-7082 单独使用对 DC 成熟分子(CD80、CD86)的表达没有影响。转化生长因子-β(TGF-)单独使用和与 BAY 11-7082 联合使用降低了这些分子的表达。在 TGF-和 BAY 11-7082 存在下,将 DC 与脾细胞共培养有利于调节性 T 细胞(CD4+CD25hiFoxP3+)的分化,不利于产生 IL-10 的 CD4+T 细胞的分化。在 CBA 小鼠中,我们发现 rmIL-10 和 rmTGF-对 DC 的成熟及其诱导 Treg 细胞和 IL-10 产生的功能特性仅有微弱影响。
这些结果表明 TGF-β 和 IL-10 对 DC 的表型和功能特征有不同的影响,而 NF-B 抑制剂 BAY 11-7082 对这些治疗没有协同作用。在免疫反应性质相反的小鼠中,免疫调节细胞因子(IL-10 和 TGF-β)对树突状细胞成熟的影响不同。